Home › DIESSE DIAGNOSTICA SENESE SPA › CHORUS INFLUENZA A IgG
CHORUS INFLUENZA A IgG
DIESSE DIAGNOSTICA SENESE SPA · Model 81190 · UDI-DI 08033891327514
10
510(k) clearances
243
Adverse events (5 deaths)
10
Recalls
12
Facilities
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2013-02-19 | Remel Inc | Flu A+ Control Swabs incorrectly give Flu A- results when used for quality control testing with the Xpect Flu A&B test kit. |
| 2012-12-03 | Quidel Corporation | Quidel Corporation has initiated a voluntary recall of specific lots of the Sofia Influenza A+B FIA kits because of false positive results which may lead to misdiagnosis. |
| 2012-03-09 | Princeton Biomeditech Corp | There have been reports of dual positive (Flu A + Flu B positive) results being encountered. |
| 2012-03-09 | Princeton Biomeditech Corp | There have been reports of dual positive (Flu A + Flu B positive) results being encountered. |
| 2012-03-09 | Princeton Biomeditech Corp | There have been reports of dual positive (Flu A + Flu B positive) results being encountered. |
| 2008-07-02 | Inverness Medical BioStar Inc. | Diagnostic kits for flu were distributed with incorrect components. |
| 2007-03-28 | Binax, Inc. dba IMPD | Tip of the foam swab could detach from the shaft causing injury to the patient. |
| 2007-03-28 | Binax, Inc. dba IMPD | Tip of the foam swab could detach from the shaft causing injury to the patient. |
| 2007-03-28 | Binax, Inc. dba IMPD | Tip of the foam swab could detach from the shaft causing injury to the patient. |
| 2007-03-28 | Binax, Inc. dba IMPD | Tip of the foam swab could detach from the shaft causing injury to the patient. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.
